Emulate, a Cambridge, Massachusetts–based developer of 'organ-on-a-chip' systems, completed a $12-million series A round led by venture capital firm NanoDimension, Cedars-Sinai Medical Center and philanthropist Hansjorg Wyss, at whose eponymous Harvard incubator the startup was formed. The technology, a computer chip surrounded by living cells that mimic human physiology, could be ready for commercialization as soon as 2016, according to Emulate CEO James Coon.